Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Roche, Novartis, Lilly, J&J: Earnings Call Roundup For Emerging Markets

This article was originally published in PharmAsia News

Executive Summary

In a recurring feature, PharmAsia News monitors major earnings calls to report on new trends in emerging market strategies.
Advertisement

Related Content

Korea's Celltrion And Aprogen In Race To Sell Biosimilars In Japan
Korea's Celltrion And Aprogen In Race To Sell Biosimilars In Japan
Nichi-Iko Takes Share Of Korean Biosimilar Firm, Gains Japanese Rights For Remicade And Herceptin Generics
Nichi-Iko Takes Share Of Korean Biosimilar Firm, Gains Japanese Rights For Remicade And Herceptin Generics
Nichi-Iko Takes Share Of Korean Biosimilar Firm Aprogen, Gains Japanese Rights For Remicade And Herceptin Generics
Chugai To Remain Unscathed By Roche's Internal Restructuring And Cost-cutting Measures
Chugai To Remain Unscathed By Roche's Internal Restructuring And Cost-cutting Measures
China's Big Cities Should Be First Priority For Pharma Companies - IMS
Lilly CEO, In Shanghai, Predicts Better Patent Protection Will Unleash Scientific Innovation Across China
Lilly CEO, In Shanghai, Predicts Better Patent Protection Will Unleash Scientific Innovation Across China
Advertisement
UsernamePublicRestriction

Register

SC074633

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel